Stage of disease confounds apparent relationship between levels of N-ras and duration of survival in head and neck tumours

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 2, 1996, Pages 73-75

  Wilson, K M ^a   Sonke, R L ^a   McDonald, J S ^a   Stambrook, P J ^a   Pavelic, L J ^a   Klusman, P ^a   Okum, E ^a   Neenan, J ^a   Gluckman, J L ^a   Pavelic, Z P ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

confounding; head and neck cancer; immunohistochemistry; N ras

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE N RAS; PRIORITY JOURNAL; SURVIVAL;

EID: 0029874290     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00081-X     Document Type: Article

References (17)

1. Guo Yc, DeSanto L, Osetinsky GV. Prognostic implications of nuclear DNA content in head and neck cancer. Otolaryngol Head Neck Surg 1989, 100, 95-98.
2. Katz AE. Immunologie staging of patients with carcinoma of the head and neck. Laryngoscope 1982, 93, 445-463.
3. Zatterstrom UK, Wennerberg J, Ewers SB, Willen R, Attewell R. Prognostic factors in head and neck cancer. Head Neck 1991, 13, 477-487.
4. Field JK. Oncogenes and tumor-suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol 1992,29B, 67-76.
5. Gapany M, Pavelic ZP, Kelley DJ, et al. Immunohistochemical detection of c-myc protein in head and neck tumors. Arch Otolaryngol Head Neck Surg 1994, 120, 255-259.
6. Pavelic ZP, Gluckman JL, Gapany M, et al. Improved immunohistochemical detection of p53 protein in paraffin embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Anticancer Res 1992, 12, 1389-1394.
7. Pavelic ZP, Pavelic LJ, Kuvelkar R, Gapany S. High c-myc expression in benign colorectal lesions correlates with the degree of dysplasia. Anticancer Res 1992, 12, 171-176.
8. Pavelic ZP, Pavelic LJ, Lower EE, et al. C-myc, c-erbB2, and Ki67 expression in normal breast tissue, invasive and non-invasive breast carcinoma. Cancer Res 1992, 52, 2597-2602.
9. Baracid M. ras genes. Am Rev Biochem 1987, 56, 779-827.
10. Bos JL. ras oncogenes in human cancer: A review. Cancer Res 1989, 49, 4682-4689.
11. Feig LA, Schaffhausen B. The hunt for ras targets. Nature 1994, 370,508-509.
12. Rodriguez-Viciana P, et al. Phosphatidylinositol-3-OH kinase as a direct target of ras. Nature 1994, 370, 527-532.
13. McDonald JS, Jones H, Pavelic ZP, Pavelic LJ, Stambrook PJ, Gluckman JL. Immunohistochemical detection of the H-ras, Kras and N-ras oncogenes in squamous cell carcinoma of the head and neck. J Oral Pathol Med 1994, 23, 342-346.
14. Paleywala S, Goldsmith LT. Detection of Ki-ras proto-oncogene protein by a specific monoclonal antibody. Bio Techniques 1991, 11,606-608.
15. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues. J Histochem Cytochem 1991, 39, 741-748.
16. Pavelic ZP, Portugal LG, Gootee MJ, et al. Retrieval of p53 protein in paraffin-embedded head and neck tumor tissues. Arch Otolaryngol Head Neck Surg 1993, 119, 1206-1209.
17. Saranath D, Panchal RG, Nair R, et al. Oncogene amplification in squamous cell carcinoma of the oral cavity. JpnJ Cancer Res 1989, 80, 430-437.